comparemela.com
Home
Live Updates
Aim Immunotech Inc - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Aim immunotech inc - Page 1 : comparemela.com
AIM ImmunoTech Announces First Dose Level is Generally
Next safety cohort to begin escalated dosing soon.
United states
Investigators at erasmus medical center
Immunotech inc
Erasmus medical center
Response evaluation criteria
Solid tumors
Nyse aim
Aim immunotech inc
Immuno oncology
Pancreatic cancer
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma
Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET.
New york
United states
Thomask equels
Immunotech inc
Chief executive officer
Medinvest biotech
Pharma investor conference
Nyse aim
Aim immunotech inc
Immuno oncology
Breast cancer
Pancreatic cancer
Ovarian cancer
Covid 19
Long covid
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023
OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will.
United states
Christopher mcaleer
Thomask equels
Immunotech inc
Chief executive officer thomas
Scientific officer christopher mcaleer
Tech conference
Nyse aim
Aim immunotech inc
Immuno oncology
Covid 19
Long covid
AIM ImmunoTech Announces First Subject Dosed in the
Phase 1b portion of the study expected to be completed within six months.
United states
Exchange commission
Immunotech inc
Erasmus medical center
Pancreato biliary surgeon
Response evaluation criteria
Private securities litigation reform act
Nyse aim
Aim immunotech inc
Pancreatic cancer
Immuno oncology
AIM ImmunoTech Reports Positive Topline Results from Phase
Efficacy results offer preliminary evidence that Ampligen may reduce fatigue in subjects with Post-COVID conditions Safety results show Ampligen is.
United states
Chris mcaleer
Thomask equels
Exchange commission
Immunotech inc
Company phase
Fatigue score
Six minute walk test
Executive officer thomas
Officer chris mcaleer
Private securities litigation reform act
Nyse aim
Aim immunotech inc
Covid 19
Long covid
vimarsana © 2020. All Rights Reserved.